Pharmacogenomics : From Basic Research to Clinical Implementation

doi:10.3390/books978-3-0365-2834-2

Download Url(s)

https://mdpi.com/books/pdfview/book/5095

Contributor(s)

Scheinfeldt, Laura B. (editor)

Language

English

Show full item record

Abstract

This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.

URI

https://directory.doabooks.org/handle/20.500.12854/81067

Keywords

pharmacogenomics; return of results; genetic counseling; qualitative; pharmacogenetics; implementation; pharmacogenetics service; screening; pre-emptive; personalized medicine; precision medicine; community pharmacy; pharmacogenomic testing; genetic privacy; pharmaco-economics; polymorphisms; pharmacogenes; pharmacogenomic; machine learning; adaptation; human evolution; US Food and Drug Administration; clinical actionability; clinical translation; chronic kidney disease; CYP3A5; polymorphism; progression; pharmacogenomics (PGx); pediatrics; best practice alerts (BPAs); electronic health records (EHR); genomic indicators; clinical decision support (CDS); phenotype; genotype; polypharmacy; chronic disease; medication management; electronic medical record; artificial intelligence; n/a